NantHealth Inc reports results for the quarter ended in December - Earnings Summary

Nanthealth

25/02/2022 01:28

* NantHealth Inc  NH.OQ  reported a quarterly adjusted loss
of 10
cents​​ per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for a loss of 8
cents per share.
    * Revenue fell 14% to $16.03 million from a year ago; 
analysts
expected $16.01 million. 
    * NantHealth Inc's reported EPS for the quarter was a loss
of 14
cents​.
    * The mean earnings estimate of analysts had fallen by
about 6.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * NantHealth Inc shares had fallen by 26.1% this quarter.
    * The company reported a quarterly loss of $16.71 million.
    * Wall Street's median 12-month price target for NantHealth
Inc is
$3.25 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated February 25 at 01:28 a.m.
 ​All figures in US dollars unless otherwise stated